Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2

被引:64
|
作者
Morisaki, H
Fujimoto, A
Ando, A
Nagata, Y
Ikeda, K
Nakanishi, M
机构
[1] NATL INST LONGEV SCI,DEPT GERIATR RES,AICHI 474,JAPAN
[2] CHIBA UNIV,GRAD SCH SCI & TECHNOL,DEPT BIOTECHNOL,MATSUDO,CHIBA 271,JAPAN
关键词
D O I
10.1006/bbrc.1997.7590
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cyclin-dependent kinase (Cdk) inhibitor p27 interrupts progression of the cell cycle by inhibiting various cyclin/Cdk activities. Since the protein level of p27 does not correlate with its mRNA level or protein synthesis rate in most cases, it is suggested that degradation of the protein may be regulated via an unidentified mechanism(s) involving a post-translational modification(s). We present evidence here that p27 phosphorylation is cell cycle-dependent and peaks in the late G1 phase and that the level of p27 protein is inversely correlated with its phosphorylation. Although both cyclin D1- and cyclin-E-dependent kinases are active in the late G1 phase in human fibroblasts, cyclin E/Cdk2 specifically phosphorylates p27 on threonine-187 in vitro. interestingly, ectopic expression of T187A revealed that it was far more stable in vivo than wild type p27. Thus, phosphorylation of p27 by cyclin El Cdk2 may affect the stability of its protein and play a role in how the protein functions. (C) 1997 Academic Press.
引用
收藏
页码:386 / 390
页数:5
相关论文
共 50 条
  • [21] Expression of the cyclin-dependent kinase inhibitor p27 in leukemias
    Petrucci, MT
    Gregorj, C
    Ariola, C
    Ricciardi, MR
    Mercurio, C
    Dominguez, JE
    Draetta, G
    Tafuri, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 29 - 29
  • [22] Expression of the cyclin-dependent kinase inhibitor p27 in keratoacanthoma
    Hu, WM
    Cook, T
    Oh, CW
    Penneys, NS
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 42 (03) : 473 - 475
  • [23] Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas - Prognostic implications
    Erlanson, M
    Portin, C
    Linderholm, B
    Lindh, J
    Roos, G
    Landberg, G
    BLOOD, 1998, 92 (03) : 770 - 777
  • [24] Interference with the function of p27 mediates induction of cyclin E cdk2 kinase by Myc
    Muller, D
    Rudolph, B
    Burgin, A
    Eilers, M
    EUROPEAN JOURNAL OF CELL BIOLOGY, 1997, 72 : 27 - 27
  • [25] A comprehensive bioinformatic analysis of cyclin-dependent kinase 2 (CDK2) in glioma
    Liu, Hengrui
    Weng, Jieling
    GENE, 2022, 822
  • [26] Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27(Kip1)
    Vlach, J
    Hennecke, S
    Amati, B
    EMBO JOURNAL, 1997, 16 (17): : 5334 - 5344
  • [27] p27, cyclin E, and CDK2 expression in normal and cancerous endometrium
    Oshita, T
    Shigemasa, K
    Nagai, N
    Ohama, K
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2002, 21 (04) : 737 - 743
  • [28] BOTH P16 AND P21 FAMILIES OF CYCLIN-DEPENDENT KINASE (CDK) INHIBITORS BLOCK THE PHOSPHORYLATION OF CYCLIN-DEPENDENT KINASES BY THE CDK-ACTIVATING KINASE
    APRELIKOVA, O
    XIONG, Y
    LIU, ET
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (31) : 18195 - 18197
  • [29] Restriction point control of the mammalian cell cycle via the cyclin E/Cdk2:p27 complex
    Conradie, Riaan
    Bruggeman, Frank J.
    Ciliberto, Andrea
    Csikasz-Nagy, Attila
    Novak, Bela
    Westerhoff, Hans V.
    Snoep, Jacky L.
    FEBS JOURNAL, 2010, 277 (02) : 357 - 367
  • [30] Inhibition of the cyclin-dependent kinase CDK2 induces hypertrophy in cardiac myocytes
    Bril, A
    Rouanet, S
    Berrebi-Bertrand, I
    Meijer, L
    CIRCULATION, 1999, 100 (18) : 627 - 627